Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Myocardial Tissue Remodeling in Adolescent Obesity
Author: Shah, RV
Abbasi, SA
Neilan, TG
Hulten, E
Coelho, O
Hoppin, A
Levitsky, L
de Ferranti, S
Rhodes, ET
Traum, A
Goodman, E
Feng, H
Heydari, B
Harris, WS
Hoefner, DM
McConnell, JP
Seethamraju, R
Rickers, C
Kwong, RY
Jerosch-Herold, M
Abstract: Background-Childhood obesity is a significant risk factor for cardiovascular disease in adulthood. Although ventricular remodeling has been reported in obese youth, early tissue-level markers within the myocardium that precede organ-level alterations have not been described. Methods and Results-We studied 21 obese adolescents (mean age, 17.7 +/- 2.6 years; mean body mass index [BMI], 41.9 +/- 9.5 kg/m(2), including 11 patients with type 2 diabetes [T2D]) and 12 healthy volunteers (age, 15.1 +/- 4.5 years; BMI, 20.1 +/- 3.5 kg/m(2)) using biomarkers of cardiometabolic risk and cardiac magnetic resonance imaging (CMR) to phenotype cardiac structure, function, and interstitial matrix remodeling by standard techniques. Although left ventricular ejection fraction and left atrial volumes were similar in healthy volunteers and obese patients (and within normal body size-adjusted limits), interstitial matrix expansion by CMR extracellular volume fraction (ECV) was significantly different between healthy volunteers (median, 0.264; interquartile range [IQR], 0.253 to 0.271), obese adolescents without T2D (median, 0.328; IQR, 0.278 to 0.345), and obese adolescents with T2D (median, 0.376; IQR, 0.336 to 0.407; P=0.0001). ECV was associated with BMI for the entire population (r=0.58, P<0.001) and with high-sensitivity C-reactive protein (r=0.47, P<0.05), serum triglycerides (r=0.51, P<0.05), and hemoglobin A1c (r=0.76, P<0.0001) in the obese stratum. Conclusions-Obese adolescents (particularly those with T2D) have subclinical alterations in myocardial tissue architecture associated with inflammation and insulin resistance. These alterations precede significant left ventricular hypertrophy or decreased cardiac function.
Subject: CT or MRI
type 2 diabetes
Country: EUA
Editor: Wiley-blackwell
Citation: Journal Of The American Heart Association. Wiley-blackwell, v. 2, n. 4, 2013.
Rights: fechado
Identifier DOI: 10.1161/JAHA.113.000279
Date Issue: 2013
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.